Cargando…
Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD
Attention-deficit hyperactivity disorder (ADHD) causes difficulties with hyperactivity, impulsivity and inattention. Treatment of ADHD includes both medication and non-pharmacological options. Knowledge of treatment preferences by young adults with ADHD is sparse. The objective of this study was to...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025481/ https://www.ncbi.nlm.nih.gov/pubmed/29671768 http://dx.doi.org/10.3390/pharmacy6020033 |
_version_ | 1783336289959936000 |
---|---|
author | Druedahl, Louise C. Kälvemark Sporrong, Sofia |
author_facet | Druedahl, Louise C. Kälvemark Sporrong, Sofia |
author_sort | Druedahl, Louise C. |
collection | PubMed |
description | Attention-deficit hyperactivity disorder (ADHD) causes difficulties with hyperactivity, impulsivity and inattention. Treatment of ADHD includes both medication and non-pharmacological options. Knowledge of treatment preferences by young adults with ADHD is sparse. The objective of this study was to explore the beliefs and experiences of young adults with ADHD related to their medication treatment decisions. Data were collected in Denmark in 2016 through a focus group and individual in-depth interviews. Conventional content analysis was used. Ten young adults with ADHD (22-to 29-year-old) participated. Three major themes were identified: (1) the patient’s right to choose concerning ADHD medicine; (2) the patient’s decision of whether or not to treat ADHD with medication; and (3) factors affecting the patient’s decision on whether to take ADHD medication or not. The latter theme contained 15 factors, which were distributed across three levels: individual, between-individuals, and societal. The dominant factors were increasing quality of life and improving oneself e.g., improving social skills. For counselling at the pharmacy and by prescribers, it is important to be aware of the different factors that affect young adult patients’ decisions on whether to take ADHD medication or not. This knowledge will aid to understand reasons for non-adherence and to determine appropriate treatment for the individual patient. |
format | Online Article Text |
id | pubmed-6025481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60254812018-07-09 Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD Druedahl, Louise C. Kälvemark Sporrong, Sofia Pharmacy (Basel) Article Attention-deficit hyperactivity disorder (ADHD) causes difficulties with hyperactivity, impulsivity and inattention. Treatment of ADHD includes both medication and non-pharmacological options. Knowledge of treatment preferences by young adults with ADHD is sparse. The objective of this study was to explore the beliefs and experiences of young adults with ADHD related to their medication treatment decisions. Data were collected in Denmark in 2016 through a focus group and individual in-depth interviews. Conventional content analysis was used. Ten young adults with ADHD (22-to 29-year-old) participated. Three major themes were identified: (1) the patient’s right to choose concerning ADHD medicine; (2) the patient’s decision of whether or not to treat ADHD with medication; and (3) factors affecting the patient’s decision on whether to take ADHD medication or not. The latter theme contained 15 factors, which were distributed across three levels: individual, between-individuals, and societal. The dominant factors were increasing quality of life and improving oneself e.g., improving social skills. For counselling at the pharmacy and by prescribers, it is important to be aware of the different factors that affect young adult patients’ decisions on whether to take ADHD medication or not. This knowledge will aid to understand reasons for non-adherence and to determine appropriate treatment for the individual patient. MDPI 2018-04-19 /pmc/articles/PMC6025481/ /pubmed/29671768 http://dx.doi.org/10.3390/pharmacy6020033 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Druedahl, Louise C. Kälvemark Sporrong, Sofia Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD |
title | Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD |
title_full | Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD |
title_fullStr | Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD |
title_full_unstemmed | Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD |
title_short | Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD |
title_sort | managing complexity: exploring decision making on medication by young adults with adhd |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025481/ https://www.ncbi.nlm.nih.gov/pubmed/29671768 http://dx.doi.org/10.3390/pharmacy6020033 |
work_keys_str_mv | AT druedahllouisec managingcomplexityexploringdecisionmakingonmedicationbyyoungadultswithadhd AT kalvemarksporrongsofia managingcomplexityexploringdecisionmakingonmedicationbyyoungadultswithadhd |